<DOC>
	<DOCNO>NCT02195180</DOCNO>
	<brief_summary>A new approach aim destroy pancreatic tumor cell modification tumor environment . Asparagine synthetase ( ASNS ) enzyme wich synthetise asparagine . Asparagine essential nutriment pancreatic cancer cell low level ASNS . L-asparaginase encapsulate erythrocyte deplete ( supress ) Plasma asparagine . select patient low ASNS , may provide new therapeutic approach .</brief_summary>
	<brief_title>Efficacy Safety L-asparaginase Encapsulated RBC Combined With Gemcitabine FOLFOX 2nd Line Progressive Metastatic Pancreatic Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<criteria>progressive metastatic exocrine pancreatic adenocarcinoma Patients available histology specimen , either primary tumor and/or metastatic lesion . eligible 2nd line gemcitabine FOLFOX4 treatment Measurable lesion ( &gt; 1cm ) assess CT scan MRI ( Magnetic Resonance Imaging ) accord RECIST criterion ( version 1.1 ) Patient age 18 year old ECOG ( WHO ) performance status 01 Signed Informed Consent Patient receive Oxaliplatine first line eligible FOLFOX arm ; Patient receive Gemcitabine first line eligible Gemcitabine arm Patient cerebral metastasis Patient resectable borderline non metastatic pancreatic adenocarcinoma Patient know hypersensitivity Lasparaginase prior exposure form Lasparaginase Antivitamin K treatment . Replacement low molecular weight heparin treatment require Patient unable receive treatment base gemcitabine FOLFOX4 ERY001 , due general visceral condition unrelated pancreatic cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Pancreas</keyword>
	<keyword>adenocarcinoma</keyword>
	<keyword>cancer</keyword>
	<keyword>asparaginase</keyword>
	<keyword>erythrocyte</keyword>
	<keyword>red blood cell</keyword>
	<keyword>Encapsulation</keyword>
	<keyword>folfox</keyword>
	<keyword>gemcitabine</keyword>
</DOC>